Advancing Frontline Care With a Quadruplet Regimen for Transplant-Ineligible Myeloma Patients

This article is sponsored by Johnson & Johnson. | Explore a quadruplet treatment regimen now approved for newly diagnosed multiple myeloma patients who are transplant ineligible.

Raccontata dafiercehealthcare.com